Advertisement
Advertisement
U.S. Markets open in 5 hrs 8 mins
Advertisement
Advertisement
Advertisement
Advertisement

Imagin Medical Inc. (IMEXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3362-0.0062 (-1.81%)
At close: 3:57PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3424
Open0.3466
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3362 - 0.3466
52 Week Range0.2330 - 1.1700
Volume2,251
Avg. Volume9,033
Market Cap3.068M
Beta (5Y Monthly)1.39
PE Ratio (TTM)N/A
EPS (TTM)-0.3420
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.

    Rapha Capital Management, LLC ("Rapha Capital") today announces it has closed a new convertible note offering totaling US $3 million in three tranches by Rapha Capital BioVentures Fund I, LP ("RCBVFI") to support the clinical development of Imagin Medical Inc.'s (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) ("Imagin" or the "Company") lead product, the i/Blue™ Imaging System. Concurrent with this financing, Kevin Slawin, M.D., a leading urooncologist and manager of the RCBVFI, w

  • GlobeNewswire

    Imagin Medical Secures New $3 Million Convertible Note Financing

    Rapha Capital BioVentures Fund I, LP (RCBVFI) leads new convertible note financing.Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board.Imagin Medical’s i/Blue™ Imaging System is poised to increase patient access to this important technology. VANCOUVER, British Columbia, BOSTON and MIAMI, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announces

  • GlobeNewswire

    Imagin Medical on Schedule for American Urology Association Demonstration

    VANCOUVER, British Columbia, and BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reports that the final design of the i/Blue Imaging System™ is on target to be demonstrated at the American Urology Association (AUA) Annual Meeting in September. The AUA Annual Meeting, in its 116th year, is the largest gathering of urologists in the world, providing education as well a

Advertisement
Advertisement